“Pfizer Inc. (PFE) Chief Executive Officer Ian Read said he is reviewing the possible sale or spinoff of four divisions with $18.3 billion in annual revenue, led by the company’s third-biggest unit, established products.
Results of the division reviews will be announced in the second half this year and in early 2012, Read said today in a telephone interview. The emerging-markets portion of New York- based Pfizer’s established-products business is big enough to stand on its own, with $915 million in sales in the first quarter, he said. No decisions have been made.”
If you enjoy the content at iBankCoin, please follow us on Twitter
